Ireland
--:--IST
Starting soon Not applicable

EQUISOCK: New Antiequine

NCT07333768 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-07-01
Last updated
2026-04-28

Condition(s) studied

Ankle (Ligaments); Instability (Old Injury)Ankle EquinusAnkle Dorsiflexion

Investigational drug(s) / intervention(s)

EQUISOCKOther ankle orthosis

EQUISOCK: Participants must wear the new ankle orthosis during assessments and in their daily lives for at least one month, which is the duration of the study.

Other ankle orthosis: Participants must wear the conventional ankle orthosis and without orthosis, during assessments and before wearing the new one

Study summary

The goal of this experimental study is to test the feasibility and validity of a new orthosis in patients with ankle lesions (external popliteal sciatic nerve or nerve injuries resulting in loss of ankle dorsiflexion) of both sexes and all ages. The main question it aims to answer is:Is the new orthosis a support for ankle stability??Does the new orthosis improve ankle function and patients' quality of life??The control group will be the subjects themselves when wearing their conventional ankle orthosis or without it. Participants must wear the new ankle orthosis for at least one month to assess the effectiveness of the orthosis and evaluate any changes that have occurred in the ankle joint and muscles.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * patients with chronic ankle injuries * patients with external popliteal sciatic nerve lesion or nerve injuries resulting in loss of ankle dorsiflexion * patients who have already been prescribed an orthosis * patients of all ages Exclusion Criteria: * inability to stand actively and stably * inability to walk unaided * inability to follow instructions

Primary outcome measure(s)

  • Device Feasibility — Baseline and up to 4 weeks
    Device feasibility will be assessed through participants' awareness of the device, as an indicator of its accessibility, visibility, and potential for effective implementation within the target population. A self diary Will be requested

Trial sites (1)

FacilityCityRegionStatus
University of Salamanca Salamanca Salamanca
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07333768 on ClinicalTrials.gov ↗ ← All trials in Spain